Innoture key facts
as of Oct 2026- Developer of microneedles and microneedle patches designed to enhance treatments via our innovative microneedle technology.
- Innoture is valued at approximately $73.8M as of Oct 2026 (last reported valuation).
- It has raised $20.2M; the latest was Later Stage VC ($8.0M) in Dec 2025.
- Notable investors include Innovate UK, Welsh Government, Ayawas Group, New Model Venture Capital.
- Status: Privately Held (backing).
Innoture's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch Innoture: the Monday email on marks, rounds and moves
Innoture funding rounds
No funding rounds for Innoture are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Innoture
4Innoture valuation
Innoture's last reported valuation was $73.8 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Innoture investors
4 investors are on record for Innoture, including Innovate UK, Welsh Government, Ayawas Group and New Model Venture Capital.
About Innoture
Developer of microneedles and microneedle patches designed to enhance treatments via our innovative microneedle technology. The company's products are small, cause minimal pain, and work by perforating the thin outer layer of the skin, allowing the medicine or vaccine to enter the body, enabling surgeons to effectively transport large molecule drugs.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2011
- Employees
- 9
- Website
- innoture.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.